Logo image of KRA

Kraton Corporation (KRA) Stock Fundamental Analysis

NYSE:KRA - New York Stock Exchange, Inc. - Common Stock

46.49  +0.01 (+0.02%)

After market: 46.48 -0.01 (-0.02%)

Fundamental Rating

2

Taking everything into account, KRA scores 2 out of 10 in our fundamental rating. KRA was compared to 84 industry peers in the Chemicals industry. KRA has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, KRA is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year KRA was profitable.
KRA Yearly Net Income VS EBIT VS OCF VS FCFKRA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 0 100M -100M 200M -200M

1.2 Ratios

Industry RankSector Rank
ROA 7.66%
ROE 25.51%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
KRA Yearly ROA, ROE, ROICKRA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 0 20 -20

1.3 Margins

Industry RankSector Rank
OM 12.93%
PM (TTM) 8.45%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
KRA Yearly Profit, Operating, Gross MarginsKRA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 0 10 -10 20

More info and screens

1

2. Health

2.1 Basic Checks

Compared to 1 year ago, KRA has more shares outstanding
The debt/assets ratio for KRA has been reduced compared to a year ago.
KRA Yearly Shares OutstandingKRA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 10M 20M 30M
KRA Yearly Total Debt VS Total AssetsKRA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 500M 1B 1.5B 2B 2.5B

2.2 Solvency

An Altman-Z score of 2.15 indicates that KRA is not a great score, but indicates only limited risk for bankruptcy at the moment.
KRA has a Debt/Equity ratio of 1.03. This is a high value indicating a heavy dependency on external financing.
Industry RankSector Rank
Debt/Equity 1.03
Debt/FCF N/A
Altman-Z 2.15
ROIC/WACCN/A
WACCN/A
KRA Yearly LT Debt VS Equity VS FCFKRA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 0 500M 1B 1.5B

2.3 Liquidity

KRA has a Current Ratio of 1.64. This is a normal value and indicates that KRA is financially healthy and should not expect problems in meeting its short term obligations.
KRA has a Quick Ratio of 1.64. This is a bad value and indicates that KRA is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 1.64
Quick Ratio 0.75
KRA Yearly Current Assets VS Current LiabilitesKRA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 200M 400M 600M 800M

More info and screens

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 121.71% over the past year.
KRA shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 4.01% yearly.
The Revenue has grown by 54.01% in the past year. This is a very strong growth!
The Revenue has been growing slightly by 2.47% on average over the past years.
EPS 1Y (TTM)121.71%
EPS 3Y-3.17%
EPS 5Y4.01%
EPS Q2Q%347.83%
Revenue 1Y (TTM)54.01%
Revenue growth 3Y-0.69%
Revenue growth 5Y2.47%
Sales Q2Q%25.95%

3.2 Future

The Earnings Per Share is expected to grow by 13.27% on average over the next years. This is quite good.
KRA is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.89% yearly.
EPS Next Y12.54%
EPS Next 2Y9.58%
EPS Next 3Y11.84%
EPS Next 5Y13.27%
Revenue Next Year-0.57%
Revenue Next 2Y2.13%
Revenue Next 3Y1.8%
Revenue Next 5Y1.89%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
KRA Yearly Revenue VS EstimatesKRA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B
KRA Yearly EPS VS EstimatesKRA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3 4

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 16.26, which indicates a correct valuation of KRA.
KRA's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 26.32.
KRA is valuated correctly with a Price/Forward Earnings ratio of 14.44.
KRA's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 22.19.
Industry RankSector Rank
PE 16.26
Fwd PE 14.44
KRA Price Earnings VS Forward Price EarningsKRA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 5.15
KRA Per share dataKRA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)1.3
PEG (5Y)4.06
EPS Next 2Y9.58%
EPS Next 3Y11.84%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for KRA!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Kraton Corporation

NYSE:KRA (3/14/2022, 8:12:45 PM)

After market: 46.48 -0.01 (-0.02%)

46.49

+0.01 (+0.02%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)N/A N/A
Earnings (Next)04-26 2022-04-26
Inst Owners1.77%
Inst Owner Change0%
Ins Owners11.54%
Ins Owner Change0%
Market Cap1.50B
Analysts48
Price Target47.43 (2.02%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 16.26
Fwd PE 14.44
P/S 0.62
P/FCF N/A
P/OCF N/A
P/B 1.88
P/tB N/A
EV/EBITDA 5.15
EPS(TTM)2.86
EY6.15%
EPS(NY)3.22
Fwd EY6.92%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS74.7
BVpS24.74
TBVpSN/A
PEG (NY)1.3
PEG (5Y)4.06
Profitability
Industry RankSector Rank
ROA 7.66%
ROE 25.51%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 12.93%
PM (TTM) 8.45%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0.91
Health
Industry RankSector Rank
Debt/Equity 1.03
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.64
Quick Ratio 0.75
Altman-Z 2.15
F-Score7
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)121.71%
EPS 3Y-3.17%
EPS 5Y4.01%
EPS Q2Q%347.83%
EPS Next Y12.54%
EPS Next 2Y9.58%
EPS Next 3Y11.84%
EPS Next 5Y13.27%
Revenue 1Y (TTM)54.01%
Revenue growth 3Y-0.69%
Revenue growth 5Y2.47%
Sales Q2Q%25.95%
Revenue Next Year-0.57%
Revenue Next 2Y2.13%
Revenue Next 3Y1.8%
Revenue Next 5Y1.89%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A